This forum is for hepatitis patients, family members, loved ones, friends or anyone with an interest in hepatitis, to have open social conversations about any topic they choose, with the exception of religion and politics. Please note that our standard “Rules for Posting in Public Areas”, which are found in our
Terms of Use , also apply in this community.
If you are newly diagnosed with Hepatitis or you have questions or information to share about current treatments, research studies, clinical trials, or other medical issues pertaining to Hepatitis, please post it in one of our Hepatitis Communities (
Hep A ,
Hep B ,
Hep C or
Hep-autoimmune ).
The problem with it that in many countries you have to pay for treatment yourself, so it really sukks that you can't do anything about it legally. Where I am, I am getting treatment free, so it would be irrelevant.
Did you ever hear of the 100 woman in Ireland who received Rhogam from the same batch after giving birth? They all ended up with hep c.
Makes you think, I received Rhogam 6 times until 1991 (that is before they could screen the blood for it) If I hadn't done any drugging right after highschool, I would be almost sure to have gotten it that way.
jd
In 1995, the risk in the United States of HIV-1 transmission per unit transfused was estimated to be between 1 in 450,000 and 1 in 660,000.(23,24) By 2003, this estimated risk had decreased to between 1 in 1.4 million and 1 in 1.8 million units.(25,26)
HIV antibody tests fail to identify HIV-infected blood donated by HIV-infected persons who have not yet seroconverted. Exclusion of donors is voluntary. Interviews with HIV antibody-positive donors reveal that most recognize their risk but fail to exclude themselves.(27) As a result, laboratory efforts to eliminate HIV-infected donors have continued and testing has improved.
Currently, HIV antibody tests detect both HIV-1 and HIV-2 and detect antibody approximately 22 days (the "window period") after the viremic phase of HIV infection begins. Antigen testing for p24, mandated by the U.S. Food and Drug Administration (FDA) in 1996, shortened the window period to approximately 16 days. The nucleic acid amplification test (NAT), which detects HIV-1 RNA in minipools (16-24 donation samples/pool), was introduced in the United States in 1999 and further reduces the window period of potential HIV transmission to 11 days.(25,26)
As of early 2003, three transfusion recipients are known to have become HIV infected by transfusion of HIV antibody-negative, p24 antigen-negative, and HIV NAT-negative blood from two different blood donors (among 25 million donations).(28)